Shockwave Medical Inc. Stock News

Healthcare technology stocks can be very lucrative investments. For evidence of that theory, take a look at the performances of three of the top names in the sector since August 2010.

ShockWave Medical (SWAV) continues to benefit from solid R&D endeavors and its commitment to clinical studies.

As we enter the final month of the first half of the year, investors' focus is on the next six months and beyond. As a result, you might be on the hunt for the best growth stocks for the second half o

Several IBD 50 stocks are forming bullishly tight chart patterns. The post These Growth Stocks Seem Stalled.

ShockWave Medical (SWAV) continues to benefit from solid R&D endeavors and its commitment to clinical studies.

Because of their longevity, predictability, and stability, healthcare trends can persist for years. The companies covered today are fundamentally and technically robust stocks currently taking advanta

Shockwave Medical's (SWAV) latest commercial availability and the patient enrollment in its study are expected to serve a wider patient pool.

Shockwave Medical Inc. NASDAQ: SWAV, the largest component within the iShares Russell 2000 ETF NYSEARCA: IWM, briefly cleared a cup-with-handle buy point on May 12, but reversed lower along with the b

Fiverr's platform for hiring freelance workers is poised to benefit from the rising popularity of artificial intelligence applications. Demand for Shockwave Medical's devices is being driven by an agi

Shockwave Medical is Thursday's IBD Stock Of The Day as SWAV stock soars closer to a breakout on its big earnings beat and raise. The post Ballooning Sales, Profit Send Shockwave Into An Early Breakou

Shockwave Medical has upped its full-year 2023 guidance after its revenue beat across all of its product segments during its first quarter. The medical product company saw its revenue increase by 72%

Shockwave Medical's (SWAV) first-quarter results reflect robust revenue growth and gross margin expansion on the back of strong demand and new launches.

Shockwave Medical, Inc. (NASDAQ:SWAV ) Q1 2023 Earnings Conference Call May 8, 2023 4:30 PM ET Company Participants Debbie Kaster - Vice President, Investor Relations Doug Godshall - President and CEO

Shockwave Medical (SWAV) came out with quarterly earnings of $1.03 per share, beating the Zacks Consensus Estimate of $0.81 per share. This compares to earnings of $0.39 per share a year ago.

SANTA CLARA, Calif., April 24, 2023 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development of Intravascular Lithotripsy (IVL) to treat complex calcified cardiovascula